—ีฐy‘fŠw‚ฬi•เ|ŒŒดy‘fˆูํว‚ึ‚ฬƒAƒvƒ[ƒ`(6)

—ีฐŒŸธ‘ช’่’l‚ฬˆูํ‚ฦ•ชŽqˆูํ

เ_@่@’ผ@F*
@@@@@@@@@@@@@@@@@@@@@@
From Abnormal Clinical Laboratory Data to Molecular Abnormality
|For Patient's Quality of Life

Naotaka HAMASAKI, MD, PhD*

When we recognize abnormal clinical data, we must investigate the causes of these abnormalities as thoroughly as possible. Although the majority of these abnormal clinical data were due to our own careless mistakes, some were due to new findings of molecular abnormalities and unexpected metabolic events. Clear determination is important for the patient's quality of life.
[Rinsho Byori 50 : 584`588, 2002]

*Department of Clinical Chemistry and Laboratory Medicine, Kyushu University Hospital, Fukuoka 812-8582

yKey Wordszabnormal clinical data(ŒŸธ‘ช’่’l‚ฬˆูํ)Cmolecular abnormality(•ชŽqˆูํ)

*‹ใB‘ๅŠwˆใŠw•”•‘ฎ•a‰@EŒŸธ•”(ง812-8582 •Ÿ‰ชŽs“Œ‹ๆ”no3-1-1)

E-mail :hamasaki@cclm.med.kyushu-u.ac.jp